Antibacterial and Anticancer Activity, Acute Toxicity, and Solubility of Co-crystals of 5-Fluorouracil and Trimethoprim

被引：6
|
作者：
Yan, Tianping [1 ]
Shu, Baoyu [1 ]
Deng, Xuezhen [1 ]
Qian, Kun [1 ]
Pan, Rongbin [2 ]
Qiu, ShouLiang [1 ]
Yang, Jie [1 ]
Fu, Qingxia [1 ]
Ma, Yuexing [3 ]
机构：
[1] Jiangxi Univ Chinese Med, Coll Pharm, Nanchang 330006, Peoples R China
[2] Jiangxi Univ Chinese Med, Integrated Chinese & Western Med Oncol Res Ctr, Nanchang 330006, Peoples R China
[3] Jiangxi Univ Tradit Chinese Med, Sci & Technol Coll, Nanchang 330004, Peoples R China
来源：
ACS OMEGA | 2023年 / 8卷 / 24期
基金：
中国国家自然科学基金;
关键词：
PHARMACEUTICAL COCRYSTALS;
D O I：
10.1021/acsomega.3c00580
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
5-Fluorouracil ismainly used for the treatment of tumorsand hasrelatively high toxicity. Trimethoprim is a common broad-spectrumantibiotic agent with extremely poor water solubility. We hoped tosolve these problems by synthesizing co-crystals (compound 1) of 5-fluorouracil and trimethoprim. Solubility tests showed thatthe solubility of compound 1 was improved compared tothat of trimethoprim. In vitro anticancer activity tests of compound 1 showed higher activity against human breast cancer cellsthan 5-fluorouracil. Acute toxicity showed that its toxicity was muchlower than that of 5-fluorouracil. In the test of anti-Shigella dysenteriae activity, compound 1 showed much stronger antibacterial activity than trimethoprim.
引用
收藏
页码：21522 / 21530
页数：9
相关论文
共 50 条
  • [31] From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine
    Dalpiaz, Alessandro
    Ferretti, Valeria
    Bertolasi, Valerio
    Pavan, Barbara
    Monari, Antonio
    Pastore, Mariachiara
    MOLECULAR PHARMACEUTICS, 2018, 15 (01) : 268 - 278
  • [32] RNA-based 5-fluorouracil toxicity requires the pseudouridylation activity of Cbf5p
    Hoskins, Jason
    Butler, J. Scott
    GENETICS, 2008, 179 (01) : 323 - 330
  • [33] Ozonation of the 5-fluorouracil anticancer drug and its prodrug capecitabine: Reaction kinetics, oxidation mechanisms, and residual toxicity
    Chen, Siyu
    Blaney, Lee
    Chen, Ping
    Deng, Shanshan
    Hopanna, Mamatha
    Bao, Yixiang
    Yu, Gang
    FRONTIERS OF ENVIRONMENTAL SCIENCE & ENGINEERING, 2019, 13 (04)
  • [34] Ozonation of the 5-fluorouracil anticancer drug and its prodrug capecitabine: Reaction kinetics, oxidation mechanisms, and residual toxicity
    Siyu Chen
    Lee Blaney
    Ping Chen
    Shanshan Deng
    Mamatha Hopanna
    Yixiang Bao
    Gang Yu
    Frontiers of Environmental Science & Engineering, 2019, 13
  • [35] Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous iv infusion of 5-fluorouracil
    Fukushima, M
    Shimamoto, Y
    Kato, T
    Uchida, J
    Yonekura, R
    Ohshimo, H
    Shirasaka, T
    ANTI-CANCER DRUGS, 1998, 9 (09) : 817 - 823
  • [36] Water-soluble copper(II) 5-fluorouracil complexes bearing polypyridyl co-ligands: synthesis, structures and anticancer activity
    Icsel, Ceyda
    Yilmaz, Veysel T.
    Aygun, Muhittin
    Erkisa, Merve
    Ulukaya, Engin
    DALTON TRANSACTIONS, 2023, 52 (21) : 7048 - 7058
  • [37] EFFECT OF CO-ADMINISTRATION OF THYMINE OR THYMIDINE ON THE ANTI-TUMOR ACTIVITY OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL AND 5-FLUOROURACIL
    FUJII, S
    KITANO, S
    IKENAKA, K
    FUKUSHIMA, M
    NAKAMURA, H
    MAEHARA, Y
    SHIRASAKA, T
    GANN, 1980, 71 (01): : 100 - 106
  • [38] Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin
    van Kuilenburg, Andre B. P.
    Klumpen, Heinz-Josef
    Westermann, Anneke M.
    Zoetekouw, Lida
    Van Lenthe, Henk
    Bakker, Piet J. M.
    Richel, Dick J.
    Guchelaar, Henk-Jan
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 459 - 465
  • [39] ANTITUMOR-ACTIVITY, TOXICITY AND INHIBITION OF THYMIDYLATE SYNTHASE OF PROLONGED ADMINISTRATION OF 5-FLUOROURACIL IN MICE
    CODACCIPISANELLI, G
    VANDERWILT, CL
    PINEDO, HM
    FRANCHI, F
    NOORDHUIS, P
    BRAAKHUIS, BJM
    VANLAAR, JAM
    PETERS, GJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (09) : 1517 - 1525
  • [40] EFFECT OF WR-2721 ON THE TOXICITY AND ANTITUMOR-ACTIVITY OF THE COMBINATION OF CARBOPLATIN AND 5-FLUOROURACIL
    VANLAAR, JAM
    VANDERWILT, CL
    TRESKES, M
    VANDERVIJGH, WJF
    PETERS, GJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 (02) : 97 - 102
12345